• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma.

作者信息

Duraković Nadira, Perić Zinaida, Kinda Sandra Bašić, Desnica Lana, Dujmović Dino, Livaja Ivo Radman, Seiwerth Ranka Serventi, Aurer Igor, Vrhovac Radovan

机构信息

Department of Internal Medicine, University of Zagreb School of Medicine, Zagreb, Croatia.

Division of Hematology, Department of Internal Medicine, Zagreb, University Hospital Center Zagreb, Croatia.

出版信息

Clin Hematol Int. 2021 Jul 15;3(3):116-118. doi: 10.2991/chi.k.210704.002. eCollection 2021 Sep.

DOI:10.2991/chi.k.210704.002
PMID:34820617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8486971/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1323/8486971/5504c493b381/CHI-3-3-116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1323/8486971/5504c493b381/CHI-3-3-116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1323/8486971/5504c493b381/CHI-3-3-116-g001.jpg

相似文献

1
The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma.异基因干细胞移植前实现完全缓解对霍奇金淋巴瘤无进展生存期的影响。
Clin Hematol Int. 2021 Jul 15;3(3):116-118. doi: 10.2991/chi.k.210704.002. eCollection 2021 Sep.
2
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens.复发或难治性淋巴瘤患者的异基因造血干细胞移植：大剂量传统预处理与氟达拉滨减低强度预处理方案的比较
Ann Oncol. 2002 Jan;13(1):135-9. doi: 10.1093/annonc/mdf010.
3
Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.氟[18F]脱氧葡萄糖正电子发射断层扫描/计算机断层扫描评估的 Deauville 评分 4 或 5 分在移植后早期高度预测淋巴瘤患者的复发。
Biol Blood Marrow Transplant. 2019 May;25(5):906-911. doi: 10.1016/j.bbmt.2018.11.019. Epub 2018 Nov 24.
4
Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.卡莫司汀、依托泊苷、阿糖胞苷和美法仑（BEAM）-抗人淋巴细胞球蛋白异基因干细胞移植治疗侵袭性非霍奇金淋巴瘤：英国血液与骨髓移植学会的疗效分析
Biol Blood Marrow Transplant. 2015 Mar;21(3):483-8. doi: 10.1016/j.bbmt.2014.11.673. Epub 2014 Dec 6.
5
The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome.正电子发射断层扫描（PET）指导下淋巴瘤自体造血干细胞移植前完全缓解的价值：一项基于人群的研究显示了更好的结果。
BMC Cancer. 2021 May 4;21(1):500. doi: 10.1186/s12885-021-08225-5.
6
Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.减低强度异基因造血干细胞移植后早期供体植入的建立，以增强移植物抗淋巴瘤效应治疗难治性淋巴瘤。
Biol Blood Marrow Transplant. 2003 Mar;9(3):162-9. doi: 10.1053/bbmt.2003.50008.
7
Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia.异基因造血干细胞移植前基于血细胞计数恢复的完全缓解对急性髓系白血病患者生存的影响
Clin Lymphoma Myeloma Leuk. 2019 May;19(5):e205-e212. doi: 10.1016/j.clml.2018.12.006. Epub 2018 Dec 21.
8
Allogeneic hematopoietic stem cell transplantation: does it have a place in treating Hodgkin lymphoma?同种异体造血干细胞移植：在治疗霍奇金淋巴瘤中是否有一席之地？
Curr Hematol Malig Rep. 2010 Oct;5(4):229-38. doi: 10.1007/s11899-010-0065-7.
9
10
Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在侵袭性淋巴瘤异基因和自体干细胞移植前的预后价值
Radiology. 2015 Nov;277(2):518-26. doi: 10.1148/radiol.2015142556. Epub 2015 Jun 2.

引用本文的文献

1
The optimal management of relapsed and refractory Hodgkin lymphoma: post-brentuximab and checkpoint inhibitor failure.复发和难治性霍奇金淋巴瘤的最佳治疗策略：博纳吐珠单抗和检查点抑制剂治疗失败后的选择。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):510-518. doi: 10.1182/hematology.2023000450.

本文引用的文献

1
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients.相合亲缘供者与 HLA 相合供者移植治疗化疗敏感的霍奇金淋巴瘤患者的比较。
BMC Cancer. 2020 Nov 24;20(1):1140. doi: 10.1186/s12885-020-07602-w.
2
Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain.接受纳武利尤单抗治疗后复发/难治性霍奇金淋巴瘤患者接受异基因造血干细胞移植的潜在生存获益：西班牙的真实世界经验。
Biol Blood Marrow Transplant. 2020 Aug;26(8):1534-1542. doi: 10.1016/j.bbmt.2020.02.003. Epub 2020 Feb 14.
3
Novel agents and immune invasion in Hodgkin lymphoma.
霍奇金淋巴瘤中的新型药物和免疫浸润。
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):243-248. doi: 10.1182/hematology.2019000029.
4
Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily.对于所有 ASCT 后复发的 HL 患者，是否都应考虑进行同种异体 SCT？需要咨询，但是不一定需要移植。
Blood Adv. 2018 Apr 10;2(7):821-824. doi: 10.1182/bloodadvances.2017011130.
5
Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?自体造血干细胞移植（SCT）后复发的所有霍奇金淋巴瘤患者是否都应考虑异体 SCT？
Blood Adv. 2018 Apr 10;2(7):817-820. doi: 10.1182/bloodadvances.2017011122.
6
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.纳武利尤单抗治疗自体造血干细胞移植后复发/难治性经典型霍奇金淋巴瘤：CheckMate 205 试验多队列单臂 2 期研究的随访扩展。
J Clin Oncol. 2018 May 10;36(14):1428-1439. doi: 10.1200/JCO.2017.76.0793. Epub 2018 Mar 27.
7
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma.移植前（18）F-氟脱氧葡萄糖-正电子发射断层扫描对霍奇金淋巴瘤T细胞去除异基因移植后生存结果的影响
Biol Blood Marrow Transplant. 2016 Jul;22(7):1234-1241. doi: 10.1016/j.bbmt.2016.03.034. Epub 2016 Apr 14.
8
Staging and response assessment in lymphomas: the new Lugano classification.淋巴瘤的分期与疗效评估：新版卢加诺分类标准
Chin Clin Oncol. 2015 Mar;4(1):5. doi: 10.3978/j.issn.2304-3865.2014.11.03.
9
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma.移植前功能成像预测复发和难治性霍奇金淋巴瘤自体干细胞移植后的结果。
Blood. 2010 Dec 2;116(23):4934-7. doi: 10.1182/blood-2010-05-282756. Epub 2010 Aug 23.
10
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability.异基因移植可改善自体移植后复发的霍奇金淋巴瘤患者的总生存和无进展生存：基于 HLA 分型和供体可用性时间的回顾性研究。
Blood. 2010 May 6;115(18):3671-7. doi: 10.1182/blood-2009-12-253856. Epub 2010 Mar 10.